See more : Sixth Street Specialty Lending, Inc. (TSLX) Income Statement Analysis – Financial Results
Complete financial analysis of DOD Biotech Public Company Limited (DOD.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DOD Biotech Public Company Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Hobonichi Co., Ltd. (3560.T) Income Statement Analysis – Financial Results
- MIRLAND-M (MLD-M.TA) Income Statement Analysis – Financial Results
- Globeride, Inc. (7990.T) Income Statement Analysis – Financial Results
- Kobay Technology Bhd. (6971.KL) Income Statement Analysis – Financial Results
- Enterprise Financial Services Corp (EFSCP) Income Statement Analysis – Financial Results
DOD Biotech Public Company Limited (DOD.BK)
About DOD Biotech Public Company Limited
DOD Biotech Public Company Limited operates as a manufacturer of dietary supplements, cosmetics, and skin care products in Thailand. It offers skincare products, which includes skin clarifying, anti-aging, moisturing, acne control, and dark spot reduction products; and body shaping products, such as metabolic boosting, carbohydrate absorption inhibitors and carb blockers, fat metabolism inhibitors, and DAppetite suppressants. The company also provides products for health care, such as brain function, bone and joints, excretory system, sleep aid, immunity boost, vitamins, and blood sugar regulators, as well as visual, hair, and cardiovascular care products; proteins for strengths and muscle function including whey/plant based proteins, power gels, and energy drinks; and body wellness products for men and ladies. It offers advisory services. The company was incorporated in 2011 and is headquartered in Mueang Samut Sakhon, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 678.15M | 537.16M | 1.02B | 1.61B | 789.92M | 666.36M | 367.58M | 384.87M | 169.72M | 2.07M | 2.07M |
| Cost of Revenue | 415.21M | 396.66M | 580.70M | 856.82M | 380.02M | 256.50M | 170.23M | 203.43M | 105.05M | 1.80M | 1.80M |
| Gross Profit | 262.94M | 140.50M | 434.62M | 754.38M | 409.91M | 409.86M | 197.35M | 181.45M | 64.67M | 270.01K | 271.10K |
| Gross Profit Ratio | 38.77% | 26.16% | 42.81% | 46.82% | 51.89% | 61.51% | 53.69% | 47.14% | 38.11% | 13.03% | 13.08% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 163.96M | 146.19M | 108.16M | 187.26M | 152.18M | 75.07M | 42.76M | 25.93M | 9.53M | 767.79K | 767.79K |
| Selling & Marketing | 84.07M | 16.86M | 18.69M | 245.95M | 177.52M | 30.19M | 17.29M | 24.23M | 8.09M | 8.09M | 0.00 |
| SG&A | 248.04M | 163.05M | 126.84M | 433.21M | 329.69M | 105.26M | 60.05M | 50.16M | 17.62M | 767.79K | 767.79K |
| Other Expenses | -41.98M | 11.17M | 3.03M | 9.39M | 6.01M | 6.76M | 791.72K | 487.42K | 212.78K | 1.09K | 0.00 |
| Operating Expenses | 206.05M | 163.05M | 126.84M | 433.21M | 329.69M | 105.26M | 60.05M | 50.16M | 17.62M | 767.79K | 767.79K |
| Cost & Expenses | 621.26M | 559.71M | 707.54M | 1.29B | 709.71M | 361.76M | 230.28M | 253.59M | 122.66M | 2.57M | 2.57M |
| Interest Income | 259.26K | 107.94K | 252.47K | 250.09K | 1.57M | 2.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 8.27M | 7.09M | 6.72M | 10.24M | 9.55M | 3.73M | 701.57K | 21.21K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 73.47M | 64.50M | 67.04M | 76.57M | 54.47M | 21.65M | 18.17M | 8.27M | 1.63M | -1.09K | 496.69K |
| EBITDA | 130.61M | -352.63M | 338.82M | 408.07M | 142.26M | 333.01M | 168.69M | 146.36M | 48.90M | -496.69K | 0.00 |
| EBITDA Ratio | 19.26% | 9.91% | 37.24% | 25.28% | 18.01% | 49.97% | 39.82% | 35.28% | 28.81% | -24.02% | 0.00% |
| Operating Income | 56.89M | -11.27M | 271.52M | 330.81M | 87.79M | 311.36M | 138.09M | 131.77M | 47.27M | -496.69K | -496.69K |
| Operating Income Ratio | 8.39% | -2.10% | 26.74% | 20.53% | 11.11% | 46.72% | 37.57% | 34.24% | 27.85% | -23.97% | -23.96% |
| Total Other Income/Expenses | -8.01M | -6.99M | -6.46M | -6.63M | -7.98M | -880.48K | -701.57K | -21.21K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 48.88M | -424.23M | 265.06M | 166.67M | 78.24M | 307.62M | 137.39M | 131.75M | 47.27M | -496.69K | -496.69K |
| Income Before Tax Ratio | 7.21% | -78.98% | 26.11% | 10.34% | 9.90% | 46.16% | 37.38% | 34.23% | 27.85% | -23.97% | -23.96% |
| Income Tax Expense | 28.06M | -79.11M | 31.96M | 33.47M | 4.73M | 2.37M | -1.39M | 2.86M | 212.78K | 1.09K | 0.00 |
| Net Income | 7.19M | -345.12M | 233.10M | 141.25M | 86.71M | 305.26M | 138.78M | 128.89M | 47.27M | -496.69K | -496.69K |
| Net Income Ratio | 1.06% | -64.25% | 22.96% | 8.77% | 10.98% | 45.81% | 37.75% | 33.49% | 27.85% | -23.97% | -23.96% |
| EPS | 0.02 | -0.84 | 0.57 | 0.34 | 0.21 | 0.85 | 0.34 | 0.31 | 0.11 | 0.00 | -0.25 |
| EPS Diluted | 0.02 | -0.84 | 0.57 | 0.34 | 0.21 | 0.84 | 0.34 | 0.31 | 0.11 | 0.00 | -0.25 |
| Weighted Avg Shares Out | 410.00M | 410.98M | 410.98M | 410.98M | 410.98M | 361.14M | 411.21M | 411.21M | 410.98M | 411.21M | 2.00M |
| Weighted Avg Shares Out (Dil) | 435.31M | 410.98M | 410.98M | 410.98M | 410.98M | 361.34M | 411.21M | 411.21M | 411.21M | 411.21M | 2.00M |
Source: https://incomestatements.info
Category: Stock Reports